SEE
56
3
AVGO
38
-25
DOW
43
-5
NWS
46
-2
MU
62
-6
IVZ
68
-5
NI
63
-4
AMT
37
-2
XYL
41
-8
PFE
39
-2
INTC
39
-5
DG
74
-2
HPE
64
-5
CVX
25
-4
AEP
59
-2
WM
56
3
FDX
53
-2
HPQ
37
-4
LYB
23
-4
ADSK
58
-4
SEE
56
3
AVGO
38
-25
DOW
43
-5
NWS
46
-2
MU
62
-6
IVZ
68
-5
NI
63
-4
AMT
37
-2
XYL
41
-8
PFE
39
-2
INTC
39
-5
DG
74
-2
HPE
64
-5
CVX
25
-4
AEP
59
-2
WM
56
3
FDX
53
-2
HPQ
37
-4
LYB
23
-4
ADSK
58
-4
Financhill
Back

Franklin Canadian Short Term Bond Fund ETF Series Vs. Nektar Therapeutics Industry Stock Comparison

Sell
42

FLSD.TO
Franklin Canadian Short Term Bond Fund ETF Series

Last Price:
$19.37
Seasonality Move:
-0.28%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.68
Seasonality Move:
11.58%
Sell
42
Franklin Canadian Short Term Bond Fund ETF Series (FLSD.TO) is a Sell

Is Franklin Canadian Short Term Bond Fund ETF Series a Buy, Sell or Hold?

  • The current Franklin Canadian Short Term Bond Fund ETF Series [FLSD.TO] share price is $19.37. The Score for FLSD.TO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • FLSD.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FLSD.TO Stock Price Chart

What is Franklin Canadian Short Term Bond Fund ETF Series's stock price today?

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

FLSD.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 37.79 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.39 - 19.51) Sell
Bollinger Bands (100): (19.34 - 19.52) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

FLSD.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.38 Sell
20-day SMA: 19.45 Sell
50-day SMA: 19.48 Sell
200-day SMA: 19.38 Sell
8-day EMA: 19.38 Sell
20-day EMA: 19.43 Sell
50-day EMA: 19.02 Buy
200-day EMA: 11.93 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Franklin Canadian Short Term Bond Fund ETF Series Earnings Growth & FLSD.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Franklin Canadian Short Term Bond Fund ETF Series Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):